Dr. Safwan Bakhsh

Medical Oncology Consultant

King Faisal Specialist Hospital and Research Center- Jeddah, Saudi Arabia

14 : 00 – 14 : 10

24 June | 2023 Day 2

Trifluridine/tipiracil plus bevacizumab for third-line treatment of refractory metastatic colorectal cancer: The phase 3 randomized SUNLIGHT study.

4th PSMMC ASCO Data Review Meeting (PADRM). This meeting will highlight the top most clinically relevant achievements of ASCO 2023 for different and commonest tumor types.